Felix S. Lee of Fenwick & West has entered an appearance for Graybug Vision Inc., a biopharmaceutical company focused on developing medicines to treat retina and optic nerve diseases, and members of its board of directors in a pending securities lawsuit over the company’s proposed merger with CalciMedica Inc. The suit, filed Dec. 28 in California Northern District Court by Weiss Law on behalf of Stephen Bushansky, contends that the proxy statement filed in support of the transaction contains false information related to the CalciMedica’s financial projections, analyses and potential conflicts of interest faced by the company’s financial adviser, Piper Sandler & Co. The case, assigned to U.S. Magistrate Judge Sallie Kim, is 3:22-cv-09131, Bushansky v. Graybug Vision, Inc. et al.
This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
